Skip to main content

CORRECTION article

Front. Pediatr., 06 November 2023
Sec. Pediatric Rheumatology
Volume 11 - 2023 | https://doi.org/10.3389/fped.2023.1323946
This article is part of the Research Topic Recurrent Fever in Pediatrics View all 6 articles

Corrigendum: Increase in pediatric recurrent fever evaluations during the first year of the COVID-19 pandemic in North America

This article is a correction to:

  1. Increase in pediatric recurrent fever evaluations during the first year of the COVID-19 pandemic in North America

    1. Read original article
\r\nLeanne M. Mansfield, &#x;Leanne M. Mansfield1,2*†Sivia K. Lapidus,&#x;Sivia K. Lapidus3,†Samira Nazzar RomeroSamira Nazzar Romero4Lakshmi N. MoorthyLakshmi N. Moorthy5Felice C. Adler-ShohetFelice C. Adler-Shohet6Matthew HollanderMatthew Hollander7Julie CherianJulie Cherian8Marinka TwiltMarinka Twilt9Geraldina LionettiGeraldina Lionetti10Smriti MohanSmriti Mohan11Patricia A. DeLaMoraPatricia A. DeLaMora12Karen L. DurrantKaren L. Durrant13Theresa Wampler MuskardinTheresa Wampler Muskardin1Mariana Correia MarquesMariana Correia Marques14Karen B. Onel,Karen B. Onel1,2Fatma Dedeoglu,Fatma Dedeoglu15,16Maria J. Gutierrez,&#x;Maria J. Gutierrez17,‡Grant Schulert,&#x;Grant Schulert18,‡the CARRA Autoinflammatory Network Consortium for the CARRA PFAPA/Autoinflammatory Working Group\r\nthe CARRA Autoinflammatory Network Consortium for the CARRA PFAPA/Autoinflammatory Working Group
  • 1Department of Pediatric Rheumatology, Hospital for Special Surgery, New York, United States
  • 2Department of Pediatrics, Weill Cornell Medicine, Cornell University, New York, United States
  • 3Joseph M. Sanzari Children’s Hospital, Hackensack, United States
  • 4Department of Rheumatology, Nemours Children’s Hospital, Orlando, United States
  • 5Department of Pediatrics, Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, New Brunswick, United States
  • 6Harbor UCLA Medical Center, Los Angeles, United States
  • 7Department of Pediatrics, Larner College of Medicine, University of Vermont, Burlington, United States
  • 8Department of Pediatrics, Stony Brook Children’s Hospital, Stony Brook, United States
  • 9Alberta Children’s Hospital, Calgary, Canada
  • 10Department of Pediatrics, School of Medicine, University of California San Francisco, San Francisco, United States
  • 11Department of Pediatrics, C. S. Mott Children’s Hospital, Ann Arbor, United States
  • 12Department of Pediatrics, School of Medicine, New York Medical College, Valhalla, United States
  • 13Autoinflammatory Alliance, San Francisco, United States
  • 14National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIH), Bethesda, United States
  • 15Division of Immunology, Boston Children’s Hospital, Harvard Medical School, Boston, United States
  • 16Department of Pediatrics, Harvard Medical School, Boston, United States
  • 17Department of Pediatrics, School of Medicine, Johns Hopkins University, Baltimore, United States
  • 18Cincinnati Children’s Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH, United States

A Corrigendum on

Increase in pediatric recurrent fever evaluations during the first year of the COVID-19 pandemic in North America

By Mansfield LM, Lapidus SK, Romero SN, Moorthy LN, Adler-Shohet FC, Hollander M, et al. (2023) Front. Pediatr. 11:1240242. doi: 10.3389/fped.2023.1240242

Incorrect Author Name

In the published article, an author name was incorrectly written as “Maria J. Guttierez”. The correct spelling is “Maria J. Gutierrez”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: pediatric, fevers, recurrent, COVID-19, rheumatology, CARRA

Citation: Mansfield LM, Lapidus SK, Romero SN, Moorthy LN, Adler-Shohet FC, Hollander M, Cherian J, Twilt M, Lionetti G, Mohan S, DeLaMora PA, Durrant KL, Muskardin TW, Correia Marques M, Onel KB, Dedeoglu F, Gutierrez MJ, Schulert G and the CARRA Autoinflammatory Network Consortium for the CARRA PFAPA/Autoinflammatory Working Group (2023) Corrigendum: Increase in pediatric recurrent fever evaluations during the first year of the COVID-19 pandemic in North America. Front. Pediatr. 11:1323946. doi: 10.3389/fped.2023.1323946

Received: 18 October 2023; Accepted: 19 October 2023;
Published: 6 November 2023.

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland

© 2023 Mansfield, Lapidus, Romero, Moorthy, Adler-Shohet, Hollander, Cherian, Twilt, Lionetti, Mohan, DeLaMora, Durrant, Muskardin, Correia Marques, Onel, Dedeoglu, Gutierrez, Schulert and the CARRA Autoinflammatory Network Consortium for the CARRA PFAPA/Autoinflammatory Working Group. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Leanne M. Mansfield leanne.m.dinges@gmail.com

†These authors share first authorship

‡These authors share senior authorship

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.